KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Thermo Fisher Scientific (TMO) Total Non-Current Liabilities (2016 - 2025)

Historic Total Non-Current Liabilities for Thermo Fisher Scientific (TMO) over the last 17 years, with Q3 2025 value amounting to $47.7 billion.

  • Thermo Fisher Scientific's Total Non-Current Liabilities rose 142.19% to $47.7 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $47.7 billion, marking a year-over-year increase of 142.19%. This contributed to the annual value of $43.7 billion for FY2024, which is 760.52% down from last year.
  • As of Q3 2025, Thermo Fisher Scientific's Total Non-Current Liabilities stood at $47.7 billion, which was up 142.19% from $46.4 billion recorded in Q2 2025.
  • In the past 5 years, Thermo Fisher Scientific's Total Non-Current Liabilities registered a high of $49.7 billion during Q4 2021, and its lowest value of $27.3 billion during Q3 2021.
  • In the last 5 years, Thermo Fisher Scientific's Total Non-Current Liabilities had a median value of $46.7 billion in 2024 and averaged $43.7 billion.
  • As far as peak fluctuations go, Thermo Fisher Scientific's Total Non-Current Liabilities skyrocketed by 7101.49% in 2022, and later crashed by 760.52% in 2024.
  • Quarter analysis of 5 years shows Thermo Fisher Scientific's Total Non-Current Liabilities stood at $49.7 billion in 2021, then fell by 1.7% to $48.9 billion in 2022, then fell by 3.14% to $47.3 billion in 2023, then dropped by 7.61% to $43.7 billion in 2024, then rose by 9.07% to $47.7 billion in 2025.
  • Its Total Non-Current Liabilities stands at $47.7 billion for Q3 2025, versus $46.4 billion for Q2 2025 and $45.7 billion for Q1 2025.